Download PDF
Minim Invasive Neurosurg 2004; 47(5): 278-283
DOI: 10.1055/s-2004-830093
Original Article
© Georg Thieme Verlag Stuttgart · New York

Impact of Neuronavigation and Image-Guided Extensive Resection for Adult Patients with Supratentorial Malignant Astrocytomas: A Single-Institution Retrospective Study

M.  Kurimoto1 , N.  Hayashi1 , H.  Kamiyama1 , S.  Nagai1 , T.  Shibata1 , T.  Asahi1 , N.  Matsumura1 , Y.  Hirashima1 , S.  Endo1
  • 1Department of Neurosurgery, Toyama Medical and Pharmaceutical University, Toyama, Japan
Further Information

Publication History

Publication Date:
02 December 2004 (online)

    Permissions and Reprints

Abstract

Neuronavigation has become an effective therapeutic modality and is used routinely for intra-axial tumor removal. This retrospective study was conducted to evaluate the clinical impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas. Between 1990 and 2002, 76 adult patients with pathologically confirmed malignant astrocytomas underwent craniotomy and removal of the tumors at the Toyama Medical and Pharmaceutical University Hospital. Of these 76 patients, 42 were treated using neuronavigation with conventional microneurosurgery and the other 34 were treated with conventional microneurosurgery alone. Postoperative early MRI with contrast enhancement was done, and gross total resection was defined as the complete absence of residual tumor. Survival time was analyzed with the Kaplan-Meier method. Prognostic factors were obtained from the Cox proportional hazards model. In univariate analysis, age (< 65), grade 3, preoperative KPS (≥ 80), use of neuronavigation, and gross total resection were significantly associated with longer survival. However, when the data were submitted to multivariate analysis, grade 3, preoperative KPS (≥ 80), and gross total resection were independent prognostic factors. The median survival periods of patients receiving gross total resection (vs. partial resection) and neuronavigation (vs. no neuronavigation) were 16 (vs. 9) months and 16 (vs. 10) months, respectively. The percentage of a gross total resection was significantly higher in the neuronavigation group compared to that in the no-navigation group (64.3 % vs. 38.2 %, p < 0.05). Neurological deterioration occurred in 4 of 42 (9.5 %) and in 6 of 34 (17.6 %) patients after surgery with neuronavigation and surgery without neuronavigation, respectively, although this difference was not statistically significant. Our results showed that neuronavigation increases the radicality in the resection of malignant astrocytomas and is objectively useful for improving survival time.

Key words

Malignant astrocytomas - neuronavigation - radical resection - survival

References

  • 1 Albert F K, Forsting M, Sartor K, Adams H P, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis.  Neurosurgery. 1994;  34 45-60
    Search in Google Scholar
  • 2 Ammirati M, Vick N, Liao Y L, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.  Neurosurgery. 1987;  21 201-206
    CrossrefPubMedSearch in Google Scholar
  • 3 Daneyemez M, Gezen F, Canakci Z, Kahraman S. Radical surgery and reoperation in supratentorial malignant glial tumors.  Minim Invasive Neurosurgery. 1998;  41 209-213
    PubMedSearch in Google Scholar
  • 4 Devaux B C, O'Fallon J R, Kelly P J. Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome.  J Neurosurg. 1993;  78 767-775
    PubMedSearch in Google Scholar
  • 5 Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.  J Neurooncol. 1994;  21 177-185
    CrossrefPubMedSearch in Google Scholar
  • 6 Keles G E, Anderson B, Berger M S. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.  Surg Neurol. 1999;  52 371-379
    CrossrefPubMedSearch in Google Scholar
  • 7 Kiwit J C, Floeth F W, Bock W J. Survival in malignant glioma. Analysis of prognostic factors with special regard to cytoreductive surgery.  Zentralbl Neurochir. 1996;  57 76-88
    PubMedSearch in Google Scholar
  • 8 Kreth F W, Berlis A, Spiropoulou V, Faist M, Scheremet R, Rossner R, Volk B, Ostertag C B. The role of tumor resection in the treatment of glioblastoma multiforme in adults.  Cancer. 1999;  86 2117-2123
    CrossrefPubMedSearch in Google Scholar
  • 9 Lacroix M, Abi-Said D, Fourney D R, Gokaslan Z L, Shi W, DeMonte F, Lang F F, McCutcheon I E, Hassenbusch S J, Holland E, Hess K, Michael C, Miller D, Sawaya R. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival.  J Neurosurg. 2001;  95 190-198
    Search in Google Scholar
  • 10 Scott J N, Rewcastle N B, Brasher P M, Fulton D, MacKinnon J A, Hamilton M, Cairncross J G, Forsyth P. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.  Ann NeuroI. 1999;  46 183-188
    PubMedSearch in Google Scholar
  • 11 Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.  J Neurooncol. 2001;  52 161-171
    CrossrefPubMedSearch in Google Scholar
  • 12 Coffey R J, Lunsford L D, Taylor F H. Survival after stereotactic biopsy of malignant gliomas.  Neurosurgery. 1988;  22 465-473
    PubMedSearch in Google Scholar
  • 13 Curran Jr W J, Scott C B, Horton J, Nelson J S, Weinstein A S, Fischbach A J, Chang C H, Rotman M, Asbell S O, Krisch R E. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.  J Natl Cancer Inst. 1993;  85 704-710
    PubMedSearch in Google Scholar
  • 14 Hess K R. Extent of resection as a prognostic variable in the treatment of gliomas.  J Neurooncol. 1999;  42 227-231
    CrossrefPubMedSearch in Google Scholar
  • 15 Hollerhage H G, Zumkeller M, Becker M, Dietz H. Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme.  Acta Neurochir (Wien). 1991;  113 31-37
    CrossrefPubMedSearch in Google Scholar
  • 16 Kreth F W, Warnke P C, Scheremet R, Ostertag C B. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.  J Neurosurg. 1993;  78 762-766
    PubMedSearch in Google Scholar
  • 17 Nazzaro J M, Neuwelt E A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults.  J Neurosurg. 1990;  73 331-344
    CrossrefPubMedSearch in Google Scholar
  • 18 Quigley M R, Maroon J C. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas.  Neurosurgery. 1991;  29 385-389
    PubMedSearch in Google Scholar
  • 19 Kowalczuk A, Macdonald R L, Amidei C, Dohrmann 3rd G, Erickson R K, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan S F, Mundt A J, Sweeney P, Vokes E E, Weir B K, Wollman R L. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.  Neurosurgery. 1997;  41 1028-1038
    PubMedSearch in Google Scholar
  • 20 Salminen E, Nuutinen I M, Huhtala S. Multivariate analysis of prognostic factors in 106 patients with malignant glioma.  Eur J Cancer. 1996;  32A 1918-1923
    PubMedSearch in Google Scholar
  • 21 Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people: A randomised study.  Acta Neurochir (Wien). 2003;  145 5-10
    CrossrefPubMedSearch in Google Scholar
  • 22 Golfinos J G, Fitzpatrick B C, Smith L R, Spetzler R F. Clinical use of a frameless stereotactic arm: Results of 325 cases.  J Neurosurg. 1995;  83 197-205
    CrossrefPubMedSearch in Google Scholar
  • 23 Gumprecht H K, Widenka D C, Lumenta C B. BrainLab VectorVision Neuronavigation System: Technology and clinical experiences in 131 cases.  Neurosurgery. 1999;  44 97-105
    CrossrefPubMedSearch in Google Scholar
  • 24 Hayashi N, Endo S, Kurimoto M, Nishijo H, Ono T, Takaku A. Functional image guided neurosurgical simulation system using computerized three-dimensional graphics and dipole tracing.  Neurosurgery. 1995;  37 694-703
    PubMedSearch in Google Scholar
  • 25 Kato A, Yoshimine T, Hayakawa T, Tomita Y, Ikeda T, Mitomo M, Harada K, Mogami H. A frameless, armless navigational system for computer-assisted neurosurgery: Technical note.  J Neurosurg. 1991;  74 845-849
    CrossrefPubMedSearch in Google Scholar
  • 26 Kelly P K, Kall B A, Goerss S, Earnest IV F. Computer-assisted stereotaxic laser resection of intra-axial brain neoplasms.  J Neurosurg. 1986;  64 427-439
    CrossrefPubMedSearch in Google Scholar
  • 27 Roberts D W, Strohbehn J W, Hatch J F, Murray W, Kettenberger H. A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope.  J Neurosurg. 1986;  65 545-549
    PubMedSearch in Google Scholar
  • 28 Roessler K, Ungersboeck K, Dietrich W, Aichholzer M, Hittmeir K, Matula C, Czech T, Koos W I. Frameless stereotactic guided neurosurgery: Clinical experience with an infrared based pointer device navigation system.  Acta Neurochir (Wien). 1997;  39 551-559
    PubMedSearch in Google Scholar
  • 29 Spetzger U, Loborde G, Glisbach J M. Frameless neuronavigation in modern neurosurgery.  Minim Invas Neurosurg. 1995;  38 163-166
    Search in Google Scholar
  • 30 Watanabe E, Watanabe T, Manaka S, Mayanagi Y, Takakura K. Three-dimensional digitizer (neuronavigator): New equipment for computed tomography-guided stereotaxic surgery.  Surg Neurol. 1987;  27 543-547
    CrossrefPubMedSearch in Google Scholar
  • 31 Wirtz C R, Albert F K, Schwaderer M, Heuer C, Staubert A, Tronnier V M, Knauth M, Kunze S. The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery.  Neurol Res. 2000;  22 354-360
    PubMedSearch in Google Scholar
  • 32 Yoshida J, Kajita Y, Wakabayashi T, Sugita K. Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation.  Acta Neurochir (Wien). 1994;  127 55-59
    CrossrefPubMedSearch in Google Scholar
  • 33 Barker 2nd F G, Chang S M, Larson D A, Sneed P K, Wara W M, Wilson C B, Prados M D. Age and radiation response in glioblastoma multiforme.  Neurosurgery. 201;  49 1288-1298
    PubMedSearch in Google Scholar
  • 34 Salcman M. The value of cytoreductive surgery.  Clin Neurosurg. 1993;  41 464-488
    PubMedSearch in Google Scholar
  • 35 Coenen V, Krings T, Mayfrank L, Polin R, Reinges M, Thron A, Gilsbach J. Three dimensional visualization of the pyramidal tract in a neuronavigation system during brain tumor surgery: First experiences and technical note.  Neurosurgery. 2001;  49 86-92
    CrossrefPubMedSearch in Google Scholar
  • 36 Jannin P, Morandi X, Fleig O. Integration of sulcal and functional information for multimodal neuronavigation.  J Neurosurg. 2002;  96 713-723
    PubMedSearch in Google Scholar
  • 37 McDonald J D, Chong B W, Lewine J D, Jones G, Burr R B, McDonald P R, Koehler S B, Tsuruda J, Orrison W W, Heilbrun M P. Integration of preoperative and intraoperative functional brain mapping in a frameless stereotactic environment for lesions near eloquent cortex: Technical note.  J Neurosurg. 1999;  90 591-598
    PubMedSearch in Google Scholar
  • 38 Roux F E, Ibarrola D, Tremoulet M, Lazorthes Y, Henry P, Sol J C, Berry I. Methodological and technical issues for integrating functional magnetic resonance imaging data in a neuronavigational system.  Neurosurgery. 2001;  49 1145-1156
    CrossrefPubMedSearch in Google Scholar
  • 39 Meyer R, Bates L, Goerss S, Friedman J, Windschitl W, Duffy J, Perkins W. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain.  Mayo Clin Proc. 2001;  76 677-687
    CrossrefPubMedSearch in Google Scholar
  • 40 Taylor M D, Bernstein M. Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: A prospective trial of 200 cases.  J Neurosurg. 1999;  90 35-41
    CrossrefPubMedSearch in Google Scholar
  • 41 Unsgaard G, Ommedal S, Muller T, Gronningsaeter A, Nagelhus Hernes T A. Neuronavigation by intraoperative three-dimensional ultrasound: Initial experience during brain tumor resection.  Neurosurgery. 2002;  50 804-812
    CrossrefPubMedSearch in Google Scholar
  • 42 Bradley W G. Achieving gross total resection of brain tumors: Intraoperative MR scanning can make a big difference.  Am J Neuroradiol. 2002;  23 348-349
    PubMedSearch in Google Scholar
  • 43 Kanner A A, Vogelbaum M A, Mayberg M R, Weisenberger J P, Barnett G H. Intracranial navigation by using low-field intraoperative magnetic resonance imaging: Preliminary experience.  J Neurosurg. 2002;  97 1115-1124
    PubMedSearch in Google Scholar
  • 44 Nimsky C, Ganslandt O, Hastreiter P, Fahlbusch R. Intraoperative compensation for brain shift.  Surg Neurol. 2001;  56 357-364
    CrossrefPubMedSearch in Google Scholar
  • 45 Germano I M, Villalobos H, Silvers A, Post K D. Clinical use of the optical digitizer for intracranial neuronavigation.  Neurosurgery. 1999;  45 261-270
    PubMedSearch in Google Scholar
  • 46 Nabavi A, Black P, Gering D. Serial intraoperative magnetic resonance imaging of brain shift.  Neurosurgery. 2001;  48 787-797
    CrossrefPubMedSearch in Google Scholar
  • 47 Schneider J P, Schulz T, Schmidt F, Dietrich J, Lieberenz S, Trantakis C, Seifert V. Gross-total surgery of supratentorial low-grade gliomas under intraoperative MR guidance.  AJNR. 2001;  22 89-98
    PubMedSearch in Google Scholar

Masanori KurimotoM. D. 

Department of Neurosurgery · Toyama Medical and Pharmaceutical University

2630 Sugitani

Toyama 930-0194

Japan

Phone: +81-764-34-7348

Fax: +81-764-34-5034 ·

Email: kuri3312@ms.toyama-mpu.ac.jp